For as long as I've been in this industry, we've measured cold chain success at the point of dispensing. Get the therapy to the pharmacy. Get it there on time, at temperature. Hand it off. Done. That model is no longer sufficient. And for the patients depending on these therapies, it never really was. The direct-to-patient surge has fundamentally r…